Btai shareholder alert: jakubowitz law reminds bioxcel shareholders of a lead plaintiff deadline of september 5, 2023

New york , aug. 4, 2023 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of bioxcel therapeutics, inc. (nasdaq: btai). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/bioxcel-class-action-loss-submission-form/?id=42954&from=4 the lawsuit seeks to recover losses for shareholders who purchased bioxcel between december 15, 2021 and june 28, 2023.
BTAI Ratings Summary
BTAI Quant Ranking